LivaNova (BSP:L2IV34) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:L2IV34 LivaNova PLC BSP:L2IV34
11 GF Score
Price R$52.47
GF Value R$39.87
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BSP:L2IV34
11GF Score
LivaNova PLC BSP:L2IV34
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is LivaNova (BSP:L2IV34) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of R$52.47 is trading 31.6% above its estimated GF Value™ of R$39.87. GuruFocus considers LivaNova to be Significantly Overvalued.

Key valuation signals for BSP:L2IV34:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: R$39.87 vs. price of R$52.47 (31.6% above fair value)
  • GF Score™: 11/100 with 7 warning signs

No single metric tells the full story. See the BSP:L2IV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIVN:USALIA:Germany
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
11GF Score

Get the complete analysis for BSP:L2IV34

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.47
Price
R$39.87
GF Value